Hims & Hers Health Inc is trading at $28.16 (3.2% up) as the stock extends a sharp three-day rebound driven by optimistic long-term growth projections.
- The company previously issued second-quarter 2026 revenue guidance of $680–$700 million, setting high expectations for sustained expansion.
- Shares have climbed from a recent low of $23.16 on June 12, recovering a significant portion of losses from a prior steep selloff.
- The move reflects a stabilization in investor sentiment as the stock recovers from a period of high historical volatility.